| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/07/2011 | US20110165069 Methods for radiolabeling macromolecules |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165065 Means for the detection and treatment of prostate cells |
| 07/07/2011 | US20110162994 Liquid Chalcogenide Compositions and Methods of Manufacturing and Using the Same |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/07/2011 | CA2785679A1 1,3,4-oxadiazole-2-carboxamide compound |
| 07/06/2011 | EP2341146A2 Method for determining chromatin structure |
| 07/06/2011 | EP2341138A1 FUSION PROTEIN COMPOSED OF MATRIX METALLOPROTEINASE-2 INHIBITOR PEPTIDE DERIVED FROM AMYLOID-beta PRECURSOR PROTEIN AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 |
| 07/06/2011 | EP2341050A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor |
| 07/06/2011 | EP2341044A1 Cycloalkylamine derivative |
| 07/06/2011 | EP2340843A1 Methods and compositions to treat myocardial conditions |
| 07/06/2011 | EP2340841A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
| 07/06/2011 | EP2340838A1 Compositions and Methods of Treatment of Cancer |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340828A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 07/06/2011 | EP2340827A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using a drug combination |
| 07/06/2011 | EP2340826A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders |
| 07/06/2011 | EP2340825A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using a neurotransmitter precursor |
| 07/06/2011 | EP2340824A2 Method and preparation for reducing the severity of ADHD and/or motor disorders |
| 07/06/2011 | EP2340822A1 Acylated 4-amidino and 4-guanidinobenzylamines for inhibiting plasma kallikreins |
| 07/06/2011 | EP2340821A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1492765B1 Novel gamma secretase inhibitors |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | EP0998291B2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/06/2011 | CN1838965B Drug for cancer therapy |
| 07/06/2011 | CN102119171A CDCA1 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102119161A Sulfur-containing heterocyclic derivative having ss-secretase-inhibiting activity |
| 07/06/2011 | CN102114210A Chinese medicine composition for treating night sweat |
| 07/06/2011 | CN102114182A Compound preparation for resisting heat stress and heat fatigue |
| 07/06/2011 | CN102114063A Method for extracting and separating asiaticoside by countercurrent extraction combined with membrane separation |
| 07/06/2011 | CN101590196B Chinese medicinal composition for clearing heat and releasing toxin, and dispelling damp heat |
| 07/06/2011 | CN101181263B Treatment of respiratory diseases |
| 07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973169 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as N-(4,5-Diphenyl-thiazol-2-yl)-benzamide, used for treating genetic disorders; respiratory system disorders |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973064 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973031 Leukemia therapy ;myelodyspastic syndrome |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972612 Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker |
| 07/05/2011 | CA2689080C Treating benign prostate hyperplasia with sarms |
| 07/05/2011 | CA2510175C 1-n-phenylamino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2470668C 5ht4 partial agonist pharmaceutical compositions |
| 07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
| 07/05/2011 | CA2450466C 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 07/05/2011 | CA2448025C Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 07/05/2011 | CA2440160C Antitumor compositions containing taxane derivatives |
| 07/05/2011 | CA2436462C Inhibitors of cruzipain and other cysteine proteases |
| 07/05/2011 | CA2423279C Phthalazinone derivatives |
| 07/05/2011 | CA2398772C Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/05/2011 | CA2380066C Antitumor antibodies, proteins, and uses thereof |
| 07/05/2011 | CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 06/30/2011 | WO2011079213A2 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | WO2011079007A1 Crth2 modulators |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078370A1 Novel parabanic acid derivative and drug having the same as active ingredient |
| 06/30/2011 | WO2011078369A1 Novel aryl urea derivative |
| 06/30/2011 | WO2011078360A1 Amide compound |
| 06/30/2011 | WO2011078323A1 Active oxygen production inhibitor and anti-hypertensive agent |
| 06/30/2011 | WO2011078306A1 Gpr119 agonist |
| 06/30/2011 | WO2011078303A1 Aminopyridine compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078204A1 Prophylactic or therapeutic agent for hyperlipemia, and anti-fatigue agent |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011078102A1 Novel phenoxypyrimidine derivative |
| 06/30/2011 | WO2011078037A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |
| 06/30/2011 | WO2011077726A1 4-amino-1,3-thiazine or oxazine derivative |
| 06/30/2011 | WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011076807A2 Lipids, lipid compositions, and methods of using them |
| 06/30/2011 | WO2011010848A3 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160302 Device and methods for treatment and prevention of tendon injuries |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160257 Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 06/30/2011 | US20110160224 Aripiprazole complex formulation and method |
| 06/30/2011 | US20110160219 Inhibitors of Phosphodiesterase Type 5A for Treating or Preventing Muscle Disease or the Symptoms Thereof in a Patient |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160148 Novel Diverse Lead Compound Autotaxin Inhibitors |
| 06/30/2011 | US20110160132 Lymphangiogenesis-promoting agents |
| 06/30/2011 | US20110160121 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159071 Isolation and Identification of Glycosaminoglycans |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159069 Medical Implants and Methods of Making Medical Implants |